🕵️ Kalvista Pharmaceuticals, Inc. ($KALV)
SEC insider & ownership activity, last 12 months · CIK 1348911 · every row links its SEC filing
Over the last 12 months insiders sold $7.6M with no open-market buying against it. Venrock Healthcare Capital Partners III, L.P. sold $3.7M (Mar). One red-flag 8-K in the window: Delisting notice (3.01), Jun 11, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 6 sellers, $7.6M (53 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 0 | – | 5 | $3.7M | Mar 26, 2026 |
| Benjamin L. Palleiko | 0 | – | 15 | $1.6M | May 22, 2026 |
| Yea Christopher | 0 | – | 11 | $1.3M | May 27, 2026 |
| Paul K. Audhya | 0 | – | 11 | $539K | May 26, 2026 |
| Sweeny Nicole | 0 | – | 7 | $285K | May 26, 2026 |
| Piekos Brian | 0 | – | 4 | $165K | May 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| VHCP Management III, LLC | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| VHCP Management EG, LLC | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| Nimish Shah | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| Bong Y Koh | 10.1% | 13G | Feb 3, 2025 | filing ↗ | |
| TANG Capital Management, LLC | 9.9% | 13G | May 15, 2025 | filing ↗ | |
| Kevin Tang | 9.9% | 13G | May 15, 2025 | filing ↗ | |
| TANG Capital Partners, LP | 6.6% | 13G | May 15, 2025 | filing ↗ | |
| Capital World Investors | 6.4% | 13G | May 13, 2025 | filing ↗ | |
| Silverarc Capital Management, LLC | 5.6% | 13G | May 13, 2026 | filing ↗ | |
| Devesh Gandhi | 5.6% | 13G | May 13, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Christopher M Yea | $905K | May 27, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jun 11, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jun 11, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jun 11, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 11, 2026 | filing ↗ |
| Delisting notice (3.01) | Jun 11, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jun 11, 2026 | filing ↗ |
| Change of control (5.01) | Jun 11, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 11, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jun 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 29, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 29, 2026 | filing ↗ |
| Earnings (2.02) | Mar 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 25, 2026 | filing ↗ |
| Earnings (2.02) | Jan 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 8, 2026 | filing ↗ |
| Earnings (2.02) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 6, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 6, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 1, 2025 | filing ↗ |
| Shareholder vote (5.07) | Oct 1, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 1, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 1, 2025 | filing ↗ |
| Material agreement (1.01) | Sep 24, 2025 | filing ↗ |
| New financial obligation (2.03) | Sep 24, 2025 | filing ↗ |